1 |
Schneider PM, Baldus SE, Metzger R, et al (2005). Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response classification. Ann Surg, 242, 684-92.
DOI
|
2 |
Scully C, Bagan J (2009). Oral squamous cell carcinoma: overview of current understanding of aetiopathogenesis and clinical implications. Oral Diseases, 15, 388-99.
DOI
|
3 |
Stewart BWW, Kleihues PI (2008). World cancer report, IARC Press.
|
4 |
Suzuki T, Sadahiro S, Fukasawa M, et al (2004). Predictive factors of tumor shrinkage and histological regression in patients who received preoperative radiotherapy for rectal cancer. Jpn J Clin Oncol, 34, 740-6.
DOI
|
5 |
Tanaka N, Odajima T, Ogi K, Ikeda T, Satoh M (2003). Expression of E-cadherin, alpha-catenin, and beta-catenin in the process of lymph node metastasis in oral squamous cell carcinoma. Br J Cancer, 89, 557-63.
DOI
ScienceOn
|
6 |
Ukpo OC, Thorstad WL, Zhang Q, Lewis JS Jr (2012). Lack of association of cadherin expression and histopathologic type, metastasis, or patient outcome in oropharyngeal squamous cell carcinoma: a tissue microarray study. Head Neck Pathol, 6, 38-47.
DOI
|
7 |
Wang X, Zhang J, Fan M, et al (2009). The expression of E-cadherin at the invasive tumor front of oral squamous cell carcinoma: immunohistochemical and RT-PCR analysis with clinicopathological correlation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 107, 547-54.
DOI
|
8 |
Woolgar JA (2006). Histopathological prognosticators in oral and oropharyngeal squamous cell carcinoma. Oral Oncol, 42, 229-39.
DOI
|
9 |
Rabinovich GA, Rubinstein N, Toscano MA (2002). Role of galectins in inflammatory and immunomodulatory processes. Biochim Biophys Acta, 1572, 274-84.
DOI
ScienceOn
|
10 |
Neville BW, Day TA (2002). Oral cancer and precancerous lesions. CA Cancer J Clin, 52, 195-215
DOI
ScienceOn
|
11 |
Nijkamp MM, Span PN, Hoogsteen IJ, et al (2011). Expression of E-cadherin and vimentin correlates with metastasis formation in head and neck squamous cell carcinoma patients. Radiother Oncol, 99, 344-8.
DOI
|
12 |
Pioche-Durieu C, Keryer C, Souqu Re S, et al (2005). In nasopharyngeal carcinoma cells, Epstein-Barr virus LMP1 interacts with galectin 9 in membrane raft elements resistant to simvastatin. J Virol, 79, 13326-37.
DOI
|
13 |
Rao SVK, Mejia G, Roberts-Thomson K, Logan R (2013). Epidemiology of oral cancer in Asia in the past decade- an update (2000-2012). Asian Pac J Cancer Prev, 14, 5567-77.
과학기술학회마을
DOI
ScienceOn
|
14 |
Rosado P, Lequerica-Fernandez P, Fernandez S, et al 2013. E-cadherin and -catenin expression in well-differentiated and moderately-differentiated oral squamous cell carcinoma: relations with clinical variables. Br J Oral Maxillofac Surg, 51, 149-56.
DOI
ScienceOn
|
15 |
Sahu N, Grandis JR (2011). New advances in molecular approaches to head and neck squamous cell carcinoma. Anti-Cancer Drugs, 22, 656-64.
DOI
|
16 |
Saussez S, Camby I, Toubeau G and Kiss R (2007). Galectins as modulators of tumor progression in head and neck squamous cell carcinomas. Head & Neck, 29, 874-84.
DOI
|
17 |
Schipper JH, Frixen UH, Behrens J, et al (1991). E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis. Cancer Research, 51, 6328-37.
|
18 |
Lopes FF, Da Costa Miguel MC, Pereira ALA, et al (2009). Changes in immunoexpression of E-cadherin and betacatenin in oral squamous cell carcinoma with and without nodal metastasis. Ann Diagn Pathol, 13, 22-9.
DOI
ScienceOn
|
19 |
Marsh R, Brackenbury R (1996). Molecules of cell adhesion and recognition: An overview. In: LEE, A. G. (ed.) Biomembranes: Receptors of cell adhesion and cellular recognition. JAI Press Inc.
|
20 |
Liu LK, Jiang XY, Zhou XX, et al (2010). Upregulation of vimentin and aberrant expression of E-cadherin/beta-catenin complex in oral squamous cell carcinomas: correlation with the clinicopathological features and patient outcome. Mod Pathol, 23, 213-24.
DOI
ScienceOn
|
21 |
Mahomed F, Altini M, Meer S (2007). Altered E-cadherin/beta-catenin expression in oral squamous carcinoma with and without nodal metastasis. Oral Diseases, 13, 386-92.
DOI
|
22 |
Matsumoto R, Matsumoto H, Seki M, et al (1998). Human ecalectin, a variant of human galectin-9, is a novel eosinophil chemoattractant produced by T lymphocytes. J Biol Chem, 273, 16976-84.
DOI
|
23 |
Menezes MB, Lehn CN, Gon Alves AJ (2007). Epidemiological and histopathological data and E-cadherin-like prognostic factors in early carcinomas of the tongue and floor of mouth. Oral Oncology, 43, 656-61.
DOI
|
24 |
Mostaan LV, Khorsandi MT, Sharifian SMR, et al (2011). Correlation between E-cadherin and CD44 adhesion molecules expression and cervical lymph node metastasis in oral tongue SCC: Predictive significance or not. Pathol Res Pract, 207, 448-51.
DOI
|
25 |
Murase N, Hosaka M, Takai Y, Tanimura T, Mori M (1985). Histochemical demonstration of lectinbinding sites and keratin in inflamed human gingiva. J Periodontal Res, 20, 625-36.
DOI
|
26 |
Irie A, Yamauchi A, Kontani K,et al (2005). Galectin-9 as a prognostic factor with antimetastatic potential in breast cancer. Clin Cancer Res, 11, 2962-8.
DOI
|
27 |
Nakahara S, Raz A (2008). Biological modulation by lectins and their ligands in tumor progression and metastasis. Anticancer Agents Med Chem, 8, 22-36.
DOI
|
28 |
Kasamatsu A, Uzawa K, Nakashima D, et al (2005). Galectin-9 as a regulator of cellular adhesion in human oral squamous cell carcinoma cell lines. Int J Mol Med, 16, 269-73.
|
29 |
Hung KF, Chang CS, Liu CJ, et al (2006). Differential expression of E-cadherin in metastatic lesions comparing to primary oral squamous cell carcinoma. J Oral Pathol Med, 35, 589-94.
DOI
|
30 |
Kageshita T, Kashio Y, Yamauchi A, et al (2002). Possible role of galectin-9 in cell aggregation and apoptosis of human melanoma cell lines and its clinical significance. Int J Cancer, 99, 809-16.
DOI
|
31 |
Kitawaki J, Kusuki I, Koshiba H, et al (1999). Detection of aromatase cytochrome P-450 in endometrial biopsy specimens as a diagnostic test for endometriosis. Fertil Steril, 72, 1100-6.
DOI
ScienceOn
|
32 |
Leffler H, Carlsson S, Hedlund M, Qian Y, Poirier F (2004). Introduction to galectins. Glycoconj J, 19, 433-40.
|
33 |
Li JJ, Zhang GH, Yang XM, et al (2012). Reduced E-cadherin expression is associated with lymph node metastases in laryngeal squamous cell carcinoma.
|
34 |
Liang M, Ueno M, Oomizu S, et al (2008). Galectin-9 expression links to malignant potential of cervical squamous cell carcinoma. J Cancer Res Clin Oncol, 134, 899-907.
DOI
|
35 |
Honjo Y, Inohara H, Akahani S, et al (2000). Expression of cytoplasmic galectin-3 as a prognostic marker in tongue carcinoma. Clin Cancer Res, 6, 4635-40.
|
36 |
Friedrichs J, Torkko JM, Helenius J, et al (2007). Contributions of galectin-3 and -9 to epithelial cell adhesion analyzed by single cell force spectroscopy. J Biol Chem, 282, 29375-83.
DOI
ScienceOn
|
37 |
Fik Z, Valach J, Chovanec M, et al (2013). Loss of adhesion/growth-regulatory galectin-9 from squamous cell epithelium in head and neck carcinomas. J Oral Pathol Med, 42, 166-73.
DOI
ScienceOn
|
38 |
Foschini MP, Cocchi R, Morandi L, et al (2008). E-cadherin loss and Delta Np73L expression in oral squamous cell carcinomas showing aggressive behavior. Head & Neck, 30, 1475-82.
DOI
ScienceOn
|
39 |
Foschini MP, Leonardi E, Eusebi LH, et al (2013). Podoplanin and E-cadherin expression in preoperative incisional biopsies of oral squamous cell carcinoma is related to lymph node metastases. Int J Surg Pathol, 21, 133-41.
DOI
ScienceOn
|
40 |
Hirashima M (2003). Multi-functions of Galectin-9. Mod Asp Immunobiol, 3, 6.
|
41 |
Cerezo L (2011). Is loss of cadherin expression predictive of high aggressiveness in oropharyngeal squamous cell carcinoma? Oral Oncology, 47, 685.
DOI
ScienceOn
|
42 |
Berchuck A, Soisson AP, Clarke-Pearson DL, et al (1989). Immunohistochemical expression of CA 125 in endometrial adenocarcinoma: correlation of antigen expression with metastatic potential. Cancer Res, 49, 2091-5.
|
43 |
Bosch FX, Abel U, Kartenbeck J (2005). E-cadherin is a selective and strongly dominant prognostic factor in squamous cell carcinoma: a comparison of E-cadherin with desmosomal components. Int J Cancer, 114, 779-90.
DOI
ScienceOn
|
44 |
Cada Z, Smetana K Jr, Lacina L, et al (2009). Immunohistochemical fingerprinting of the network of seven adhesion/growthregulatory lectins in human skin and detection of distinct tumour-associated alterations. Folia Biologica, 55, 145-52.
|
45 |
Chen HY, Lo CH, Li CS, Hsu DK, Liu FT (2012). Galectins and cutaneous immunity. Dermatologica Sinica, 30, 121-7.
DOI
ScienceOn
|
46 |
Christofori G & Semb H (1999). The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene. Trends Biochem Sci, 24, 73-6.
DOI
ScienceOn
|
47 |
Edge SE, Byrd DR, Compton CC, et al (2010). AJCC Cancer Staging Manual New York, USA, Springer.
|
48 |
Cooper DN, Barondes SH (1999). God must love galectins; he made so many of them. Glycobiology, 9, 979-84.
DOI
ScienceOn
|
49 |
Diniz-Freitas M, Garcia-Caballero T, Antunez-Lopez J, Gandara-Rey JM, Garcia-Garcia A (2006). Reduced E-cadherin expression is an indicator of unfavourable prognosis in oral squamous cell carcinoma. Oral Oncol, 42, 190-200.
|
50 |
Dorta RG, Landman G, Kowalski LP, et al (2002). Tumourassociated tissue eosinophilia as a prognostic factor in oral squamous cell carcinomas. Histopathology, 41, 152-7.
|
51 |
Alberts B, Johnson A, Lewis J, et al (2002). Cell-Cell Adhesion. Molecular Biology of the Cell. 4 ed. New York: Garland Science.
|
52 |
Alves PM, Godoy GP, Gomes DQ, et al (2011). Significance of galectins-1, -3, -4 and -7 in the progression of squamous cell carcinoma of the tongue. Pathol Res Pract, 207, 236-40.
DOI
ScienceOn
|
53 |
Balan V, Nangia-Makker P, Raz A (2010). Galectins as cancer biomarkers. Cancers, 2, 592-610.
DOI
ScienceOn
|
54 |
Smetana K Jr, Dvor Nkov B, Chovanec M, et al (2006). Nuclear presence of adhesion-/growth-regulatory galectins in normal/malignant cells of squamous epithelial origin. Histochem Cell Biol, 125, 171-82.
DOI
|
55 |
Yamada K, Jordan R, Mori M, Speight PM (1997). The relationship between E-cadherin expression, clinical stage and tumour differentiation in oral squamous cell carcinoma. Oral Diseases, 3, 82-5.
|
56 |
Zhao Z, Ge J, Sun Y, et al (2012). Is E-cadherin immunoexpression a prognostic factor for head and neck squamous cell carcinoma (HNSCC)? A systematic review and metaanalysis. Oral Oncol, 48, 761-7.
DOI
|
57 |
Zhong LP, Li J, Zhang CP, et al (2007). Expression of E-cadherin in cervical lymph nodes from primary oral squamous cell carcinoma patients. Arch Oral Biol, 52, 740-7.
DOI
|